PIAS1 and posterior cortical atrophy: In order to address the question if PIAS1 targeting can be used for an improved PCa therapy, we analyzed PIAS1 expression in primary tumors of all stages, in metastatic lesions, in tissue of patients after chemotherapy with docetaxel, and in docetaxel resistant cell lines.